Library › Molecules › Approved drugs · Cancer & immunomodulators

Approved drugs · Cancer & immunomodulators: 94 3D models

Water, gases, sugars, nucleotides, amino acids, ions (real sizes 0.1–1 nm). Each one is a ready-made 3D model you can turn, recolour and place in a figure — open BioDioRama and type its name in the Library search.

Open the 3D Studio

Mechlorethamine — Approved medicine — antineoplastic agents, first approved 1949. C5H11Cl2N, 156.06 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Amsacrine — Approved medicine — antineoplastic agents, first approved 1987. C21H19N3O3S, 393.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Aminoglutethimide — Approved medicine — endocrine therapy, first approved 1980. C13H16N2O2, 232.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Plerixafor — Approved medicine — immunostimulants, first approved 2008. C28H54N8, 502.8 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Tegafur — Approved medicine — antineoplastic agents. C8H9FN2O3, 200.17 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Anagrelide — Approved medicine — antineoplastic agents, first approved 1997. C10H7Cl2N3O, 256.09 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Flutamide — Approved medicine — endocrine therapy, first approved 1989. C11H11F3N2O3, 276.21 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Omacetaxine mepesuccinate — Approved medicine — antineoplastic agents, first approved 2009. C29H39NO9, 545.63 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Floxuridine — Approved medicine — antineoplastic agents, first approved 1970. C9H11FN2O5, 246.19 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Bexarotene — Approved medicine — antineoplastic agents, first approved 1999. C24H28O2, 348.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Masoprocol — Approved medicine — antineoplastic agents, first approved 1992. C18H22O4, 302.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Trifluridine — Approved medicine — antineoplastic agents, first approved 1980. C10H11F3N2O5, 296.2 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nilutamide — Approved medicine — endocrine therapy, first approved 1996. C12H10F3N3O4, 317.22 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Procarbazine — Approved medicine — antineoplastic agents, first approved 1969. C12H19N3O, 221.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pixantrone — Approved medicine — antineoplastic agents, first approved 2012. C17H19N5O2, 325.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Neratinib — Approved medicine — antineoplastic agents, first approved 2017. C30H29ClN6O3, 557.05 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Raltitrexed — Approved medicine — antineoplastic agents. C21H22N4O6S, 458.5 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Altretamine — Approved medicine — antineoplastic agents, first approved 1990. C9H18N6, 210.28 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Vindesine — Approved medicine — antineoplastic agents. C43H55N5O7, 753.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Uracil mustard — Approved medicine — antineoplastic agents, first approved 1962. C8H11Cl2N3O2, 252.1 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Belinostat — Approved medicine — antineoplastic agents, first approved 2014. C15H14N2O4S, 318.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Treosulfan — Approved medicine — antineoplastic agents, first approved 2019. C6H14O8S2, 278.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Teniposide — Approved medicine — antineoplastic agents, first approved 1992. C32H32O13S, 656.66 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pentostatin — Approved medicine — antineoplastic agents, first approved 1991. C11H16N4O4, 268.27 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pipobroman — Approved medicine — antineoplastic agents, first approved 1966. C10H16Br2N2O2, 356.06 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Apremilast — Approved medicine — immunosuppressants, first approved 2014. C22H24N2O7S, 460.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Temoporfin — Approved medicine — antineoplastic agents, first approved 2001. C44H32N4O4, 680.76 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Plitidepsin — Approved medicine — antineoplastic agents, first approved 2018. C57H87N7O15, 1110.36 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Toremifene — Approved medicine — endocrine therapy, first approved 1996. C26H28ClNO, 405.97 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mitotane — Approved medicine — antineoplastic agents, first approved 1970. C14H10Cl4, 320.05 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mavorixafor — Approved medicine — immunostimulants, first approved 2024. C21H27N5, 349.48 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nintedanib — Approved medicine — antineoplastic agents, first approved 2014. C31H33N5O4, 539.64 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Quizartinib — Approved medicine — antineoplastic agents, first approved 2023. C29H32N6O4S, 560.68 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Momelotinib — Approved medicine — antineoplastic agents, first approved 2023. C23H22N6O2, 414.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Methyl aminolevulinate — Approved medicine — antineoplastic agents, first approved 2004. C6H11NO3, 145.16 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Valrubicin — Approved medicine — antineoplastic agents, first approved 1998. C34H36F3NO13, 723.65 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ponesimod — Approved medicine — immunosuppressants, first approved 2021. C23H25ClN2O4S, 460.98 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Diethylstilbestrol diphosphate — Approved medicine — endocrine therapy, first approved 1982. C18H22O8P2, 428.31 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nelarabine — Approved medicine — antineoplastic agents, first approved 2005. C11H15N5O5, 297.27 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Temsirolimus — Approved medicine — antineoplastic agents, first approved 2007. C56H87NO16, 1030.3 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Plicamycin — Approved medicine — antineoplastic agents, first approved 1970. C52H76O24, 1085.16 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pirfenidone — Approved medicine — immunosuppressants, first approved 2011. C12H11NO, 185.23 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Fedratinib — Approved medicine — antineoplastic agents, first approved 2019. C27H36N6O3S, 524.69 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Tivozanib — Approved medicine — antineoplastic agents, first approved 2017. C22H19ClN4O5, 454.87 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Selumetinib — Approved medicine — antineoplastic agents, first approved 2020. C17H15BrClFN4O3, 457.69 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Nirogacestat — Approved medicine — antineoplastic agents, first approved 2023. C27H41F2N5O, 489.66 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Relugolix — Approved medicine — endocrine therapy. C29H27F2N7O5S, 623.64 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Infigratinib — Approved medicine — antineoplastic agents, first approved 2021. C26H31Cl2N7O3, 560.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Streptozocin — Approved medicine — antineoplastic agents, first approved 1982. C8H15N3O7, 265.22 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Belumosudil — Approved medicine — immunosuppressants, first approved 2021. C26H24N6O2, 452.52 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pacritinib — Approved medicine — antineoplastic agents, first approved 2022. C28H32N4O3, 472.59 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Glasdegib — Approved medicine — antineoplastic agents, first approved 2018. C21H22N6O, 374.45 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Dacomitinib — Approved medicine — antineoplastic agents, first approved 2018. C24H27ClFN5O3, 487.96 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Sonidegib — Approved medicine — antineoplastic agents, first approved 2015. C26H26F3N3O3, 485.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mifamurtide — Approved medicine — immunostimulants, first approved 2009. C59H110N6NaO20P, 1277.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Vinflunine — Approved medicine — antineoplastic agents, first approved 2009. C45H54F2N4O8, 816.94 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Siponimod — Approved medicine — immunosuppressants, first approved 2019. C29H35F3N2O3, 516.6 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Duvelisib — Approved medicine — antineoplastic agents, first approved 2018. C22H17ClN6O, 416.87 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Peficitinib — Approved medicine — immunosuppressants, first approved 2019. C18H22N4O2, 326.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Capmatinib — Approved medicine — antineoplastic agents, first approved 2020. C23H17FN6O, 412.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Copanlisib — Approved medicine — antineoplastic agents, first approved 2017. C23H28N8O4, 480.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Filgotinib — Approved medicine — immunosuppressants, first approved 2020. C21H23N5O3S, 425.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Etrasimod — Approved medicine — immunosuppressants, first approved 2023. C26H26F3NO3, 457.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Tepotinib — Approved medicine — antineoplastic agents, first approved 2021. C29H28N6O2, 492.58 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Erdafitinib — Approved medicine — antineoplastic agents, first approved 2019. C25H30N6O2, 446.56 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Leniolisib — Approved medicine — immunostimulants, first approved 2023. C21H25F3N6O2, 450.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Futibatinib — Approved medicine — antineoplastic agents, first approved 2022. C22H22N6O3, 418.46 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ozanimod — Approved medicine — immunosuppressants, first approved 2020. C23H24N4O3, 404.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Olmutinib — Approved medicine — antineoplastic agents, first approved 2016. C26H26N6O2S, 486.6 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pexidartinib — Approved medicine — antineoplastic agents, first approved 2019. C20H15ClF3N5, 417.82 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Umbralisib — Approved medicine — antineoplastic agents, first approved 2021. C31H24F3N5O3, 571.56 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Tucatinib — Approved medicine — antineoplastic agents, first approved 2020. C26H24N8O2, 480.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Avacopan — Approved medicine — immunosuppressants, first approved 2021. C33H35F4N3O2, 581.65 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Tirabrutinib — Approved medicine — antineoplastic agents, first approved 2020. C25H22N6O3, 454.49 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ritlecitinib — Approved medicine — immunosuppressants, first approved 2023. C15H19N5O, 285.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Avapritinib — Approved medicine — antineoplastic agents, first approved 2020. C26H27FN10, 498.57 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Asciminib — Approved medicine — antineoplastic agents, first approved 2021. C20H18ClF2N5O3, 449.85 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Ripretinib — Approved medicine — antineoplastic agents, first approved 2020. C24H21BrFN5O2, 510.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Danicopan — Approved medicine — immunosuppressants, first approved 2024. C26H23BrFN7O3, 580.42 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Vorasidenib — Approved medicine — antineoplastic agents, first approved 2024. C14H13ClF6N6, 414.74 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Elacestrant — Approved medicine — endocrine therapy, first approved 2023. C30H38N2O2, 458.65 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pemigatinib — Approved medicine — antineoplastic agents, first approved 2020. C24H27F2N5O4, 487.51 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Olutasidenib — Approved medicine — antineoplastic agents, first approved 2022. C18H15ClN4O2, 354.8 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Repotrectinib — Approved medicine — antineoplastic agents, first approved 2023. C18H18FN5O2, 355.37 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Melphalan flufenamide — Approved medicine — antineoplastic agents, first approved 2021. C24H30Cl2FN3O3, 498.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Fruquintinib — Approved medicine — antineoplastic agents, first approved 2023. C21H19N3O5, 393.4 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Deucravacitinib — Approved medicine — immunosuppressants, first approved 2022. C20H22N8O3, 425.47 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Lazertinib — Approved medicine — antineoplastic agents, first approved 2024. C30H34N8O3, 554.66 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Selpercatinib — Approved medicine — antineoplastic agents, first approved 2020. C29H31N7O3, 525.61 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pralsetinib — Approved medicine — antineoplastic agents, first approved 2020. C27H32FN9O2, 533.61 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Belzutifan — Approved medicine — antineoplastic agents, first approved 2021. C17H12F3NO4S, 383.35 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Iptacopan — Approved medicine — immunosuppressants, first approved 2023. C25H30N2O4, 422.53 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Mobocertinib — Approved medicine — antineoplastic agents, first approved 2021. C32H39N7O4, 585.71 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.
Pirtobrutinib — Approved medicine — antineoplastic agents, first approved 2023. C22H21F4N5O3, 479.43 g/mol. Real 3D structure from PubChem. “Show as” draws it as tablets, capsules, syrup, an injection and other dosage forms.